Cancer is getting younger, and Charlotte-area women are on the front line. Clinics in Charlotte and the nearby Triangle are seeing more middle-aged and even younger women walk in with cancers that not long ago showed up mostly in older adults. North Carolina resident Lynn Bare was 54 when she learned in 2020 that she had endometrial cancer. She later enrolled in a Duke clinical trial that paired immunotherapy with chemotherapy, hoping her case might also help future patients. Physicians say what she is living through reflects a complicated mix of biology, lifestyle and environmental exposures rather than a single smoking gun.
What the Data Show
According to the American Cancer Society, overall cancer death rates have dropped, yet diagnoses among women have climbed. In the most recent incidence data, women under 50 had cancer rates roughly 82% higher than men in the same age group. The report also highlights rising rates in several cancers that disproportionately affect women, including breast, thyroid, liver and pancreatic cancers, with those trends building over the past two decades.
Local Patients and Doctors
As reported by WBTV, Bare joined a Duke Cancer Institute trial after her diagnosis and has become a clear example of the shift clinicians are watching. Dr. Rhea Rogers, quoted in that coverage, said, “There's an overload of hormones that start at a very young age,” and pointed to inflammation tied to diet, disrupted sleep and chronic stress as likely contributors. Those exam-room observations track with the broader surveillance data and help explain why specialists are pushing harder on research and trial enrollment.
Duke Research and Trials
The Duke Department of Obstetrics and Gynecology reports that it has expanded its work on endometrial and other gynecologic cancers, building an Endometrial Cancer Consortium that now spans 25 sites to study tumor biology and why some cancers resist treatment. Duke clinicians have also stressed that funding and access have not kept pace, even as new immunotherapy-plus-chemotherapy combinations move into multicenter trials.
A National Paradox
Nationally, the National Cancer Institute points to a paradox. Cancer deaths have fallen sharply since the 1990s, yet incidence among women rose slightly year after year through 2021. That split, with better survival on one side and more diagnoses on the other, is driving a stronger focus on what is happening upstream and on finding cancers earlier, when today’s treatments have the best shot at working.
Screening and Prevention
Doctors keep coming back to two themes: prevention and timing. The American Cancer Society recommends that average-risk adults start colorectal cancer screening at age 45. The U.S. Preventive Services Task Force now advises most women to get mammograms every other year starting at age 40. Clinicians say anyone with new or unusual symptoms, including abnormal bleeding, a new lump, persistent pain or unexplained weight loss, should get checked rather than waiting for the next routine screening date.
Where to Find Help Locally
For people in the Triangle and Charlotte looking for screening, clinical trials or patient support, appointment and trial details are available through the Duke Cancer Institute and other regional health systems. Primary-care providers, local health departments and cancer support organizations remain the best first stop for questions about personal risk, screening schedules and whether a clinical trial might be a fit.
